These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 6223812

  • 21. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
    O'Hare MD, Felmingham D, Grüneberg RN.
    Drugs Exp Clin Res; 1988; 14(10):617-9. PubMed ID: 2977587
    [Abstract] [Full Text] [Related]

  • 22. Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.
    Pallanza R, Berti M, Goldstein BP, Mapelli E, Randisi E, Scotti R, Arioli V.
    J Antimicrob Chemother; 1983 May; 11(5):419-25. PubMed ID: 6223907
    [Abstract] [Full Text] [Related]

  • 23. Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria.
    Eliopoulos GM, Wennersten CB, Moellering RC.
    Diagn Microbiol Infect Dis; 1996 May; 25(1):35-41. PubMed ID: 8831043
    [Abstract] [Full Text] [Related]

  • 24. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA, Beaulieu S, Arhin FF, Belley A, Sarmiento I, Parr T, Moeck G.
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [Abstract] [Full Text] [Related]

  • 25. Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16.
    Pfaller MA, Mendes RE, Duncan LR, Flamm RK, Sader HS.
    J Antimicrob Chemother; 2018 Oct 01; 73(10):2748-2756. PubMed ID: 29982565
    [Abstract] [Full Text] [Related]

  • 26. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Moorhouse EC, Mulvihill TE, Jones L, Mooney D, Falkiner FR, Keane CT.
    J Antimicrob Chemother; 1985 Mar 01; 15(3):291-5. PubMed ID: 3158632
    [Abstract] [Full Text] [Related]

  • 27. Comparative in vitro activity of vancomycin and other antimicrobial agents against methicillin-resistant staphylococcus aureus and enterococcus faecium in the Tohoku district of Japan.
    Lutfor AB, Kikuchi T, Tokue Y, Takahashi H, Shoji S, Fujimura S, Nukiwa T, Watanabe A.
    Chemotherapy; 1998 Mar 01; 44(5):318-23. PubMed ID: 9732146
    [Abstract] [Full Text] [Related]

  • 28. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M, Asari S, Nishi I, Horikawa M, Tsukamoto H, Sunada A, Ueda A, Iwatani Y.
    J Chemother; 2003 Feb 01; 15(1):31-6. PubMed ID: 12678411
    [Abstract] [Full Text] [Related]

  • 29. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
    Dixson S, Brumfitt W, Hamilton-Miller JM.
    Eur J Clin Microbiol; 1985 Feb 01; 4(1):19-23. PubMed ID: 3157567
    [Abstract] [Full Text] [Related]

  • 30. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
    Del Bene VE, John JF, Twitty JA, Lewis JW.
    J Infect Dis; 1986 Aug 01; 154(2):349-52. PubMed ID: 2941491
    [No Abstract] [Full Text] [Related]

  • 31. Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model.
    Blenkharn JI, Darrell JH.
    Eur J Clin Microbiol Infect Dis; 1989 Aug 01; 8(8):734-7. PubMed ID: 2550236
    [Abstract] [Full Text] [Related]

  • 32. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
    Kenny MT, Dulworth JK, Brackman MA.
    Diagn Microbiol Infect Dis; 1991 Aug 01; 14(1):29-31. PubMed ID: 1826479
    [Abstract] [Full Text] [Related]

  • 33. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M, Hidalgo Orozco R, Rodríguez Garrido S, Gaona Álvarez C, Sánchez Silos RM, Hernández Rastrollo R, Martínez Tallo E, Cordero Carrasco JL.
    Rev Esp Quimioter; 2012 Mar 01; 25(1):25-30. PubMed ID: 22488538
    [Abstract] [Full Text] [Related]

  • 34. Activity of daptomycin against enterococci and coagulase-negative staphylococci (CNS): relationship between CNS susceptibility and slime production.
    Marone P, Perversi L, Navarra A, Monzillo V, Sartirana E.
    J Chemother; 1993 Jun 01; 5(3):151-4. PubMed ID: 8396625
    [Abstract] [Full Text] [Related]

  • 35. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK, Mermel LA, LaPlante KL.
    Am J Health Syst Pharm; 2017 May 01; 74(9):e193-e201. PubMed ID: 28438824
    [Abstract] [Full Text] [Related]

  • 36. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
    Barry AL, Jones RN, Gavan TL, Thornsberry C.
    J Clin Microbiol; 1987 Sep 01; 25(9):1812-4. PubMed ID: 2958498
    [Abstract] [Full Text] [Related]

  • 37. Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility.
    Howe RA, Wootton M, Bennett PM, MacGowan AP, Walsh TR.
    J Clin Microbiol; 1999 Sep 01; 37(9):3068-71. PubMed ID: 10449511
    [Abstract] [Full Text] [Related]

  • 38. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J, Kresken M, Menke A, Orland A, Weiher H, Morrissey I.
    Int J Antimicrob Agents; 2007 Mar 01; 29(3):322-5. PubMed ID: 17204403
    [Abstract] [Full Text] [Related]

  • 39. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
    Cohen R, Barre J, Varon E.
    Pathol Biol (Paris); 1992 Oct 01; 40(8):831-44. PubMed ID: 1484744
    [Abstract] [Full Text] [Related]

  • 40. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V.
    J Med Assoc Thai; 1991 Dec 01; 74(12):669-74. PubMed ID: 1839906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.